PH23341A - Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereof - Google Patents
Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereofInfo
- Publication number
- PH23341A PH23341A PH33785A PH33785A PH23341A PH 23341 A PH23341 A PH 23341A PH 33785 A PH33785 A PH 33785A PH 33785 A PH33785 A PH 33785A PH 23341 A PH23341 A PH 23341A
- Authority
- PH
- Philippines
- Prior art keywords
- compounds
- pharmaceutical composition
- composition containing
- morphinane derivatives
- morphinane
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 150000003809 morphinane derivatives Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3518525 | 1985-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH23341A true PH23341A (en) | 1989-07-14 |
Family
ID=6271435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH33785A PH23341A (en) | 1985-05-23 | 1986-05-19 | Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereof |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS61271275A (en) |
| AU (1) | AU594954B2 (en) |
| BE (1) | BE904796A (en) |
| DK (1) | DK240386A (en) |
| ES (1) | ES8802318A1 (en) |
| FI (1) | FI862124L (en) |
| FR (1) | FR2582309B1 (en) |
| GB (1) | GB2175898B (en) |
| GR (1) | GR861318B (en) |
| HU (1) | HU196376B (en) |
| IL (1) | IL78872A0 (en) |
| IT (1) | IT1203791B (en) |
| LU (1) | LU86435A1 (en) |
| NL (1) | NL8601188A (en) |
| NZ (1) | NZ216250A (en) |
| PH (1) | PH23341A (en) |
| SE (1) | SE8602308L (en) |
| ZA (1) | ZA863873B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
| US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
| US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
| JP2906654B2 (en) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | Immunosuppressant and method for producing the same |
| US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
| DK0577847T3 (en) * | 1992-01-23 | 1999-06-23 | Toray Industries | Morphine derivative and its medical use |
| DE69414085T2 (en) * | 1993-07-19 | 1999-03-18 | Toray Industries, Inc., Tokio/Tokyo | ACTIVE SUBSTANCE TO PROTECT BRAIN CELLS |
| JP3843456B2 (en) * | 1993-07-23 | 2006-11-08 | 東レ株式会社 | Morphinan derivatives and pharmaceutical applications |
| AR005423A1 (en) | 1996-01-10 | 1999-06-23 | Smithkline Beecham Spa | MORPHINOID DERIVATIVES CONDENSED WITH HETERO CYCLES (II), THEIR USE AS A THERAPEUTIC SUBSTANCE AND TO PREPARE MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE TO PREPARE SUCH DERIVATIVES. |
| CN1291717C (en) * | 1996-11-25 | 2006-12-27 | 东丽株式会社 | Antipruritic |
| AU6117298A (en) * | 1997-07-25 | 1999-02-16 | Toray Industries, Inc. | Hyponatremia remedies |
| US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| EP1506174B1 (en) | 2002-05-17 | 2015-09-30 | Taiwanj Pharmaceuticals Co., Ltd. | Use of naltrexone for treating kidney and liver damage |
| JP4957489B2 (en) * | 2002-10-09 | 2012-06-20 | 東レ株式会社 | Pharmaceutical containing morphinan derivative having nitrogen-containing cyclic substituent or pharmacologically acceptable acid addition salt thereof |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US8354534B2 (en) * | 2008-02-14 | 2013-01-15 | Alkermes, Inc. | Selective opioid compounds |
| US8987287B2 (en) * | 2012-12-14 | 2015-03-24 | Purdue Pharma L.P. | Spirocyclic morphinans and their use |
| US8980906B2 (en) * | 2012-12-14 | 2015-03-17 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
| AR096851A1 (en) * | 2013-07-11 | 2016-02-03 | H Lundbeck As | SALTS THAT DO NOT FORM HYDRATS OR SOLVATOS DE NALMEFENO |
| JP6360915B2 (en) * | 2014-06-13 | 2018-07-18 | パーデュー、ファーマ、リミテッド、パートナーシップ | Azamorphinan derivatives and uses thereof |
-
1986
- 1986-05-09 HU HU861934A patent/HU196376B/en not_active IP Right Cessation
- 1986-05-12 NL NL8601188A patent/NL8601188A/en not_active Application Discontinuation
- 1986-05-19 PH PH33785A patent/PH23341A/en unknown
- 1986-05-19 GB GB8612159A patent/GB2175898B/en not_active Expired
- 1986-05-21 AU AU57637/86A patent/AU594954B2/en not_active Expired - Fee Related
- 1986-05-21 ES ES555200A patent/ES8802318A1/en not_active Expired
- 1986-05-21 SE SE8602308A patent/SE8602308L/en not_active Application Discontinuation
- 1986-05-21 GR GR861318A patent/GR861318B/en unknown
- 1986-05-21 IL IL78872A patent/IL78872A0/en unknown
- 1986-05-21 BE BE1/011493A patent/BE904796A/en not_active IP Right Cessation
- 1986-05-21 FI FI862124A patent/FI862124L/en not_active Application Discontinuation
- 1986-05-21 NZ NZ216250A patent/NZ216250A/en unknown
- 1986-05-22 LU LU86435A patent/LU86435A1/en unknown
- 1986-05-22 JP JP61118984A patent/JPS61271275A/en active Pending
- 1986-05-22 DK DK240386A patent/DK240386A/en not_active Application Discontinuation
- 1986-05-23 IT IT48050/86A patent/IT1203791B/en active
- 1986-05-23 FR FR8607367A patent/FR2582309B1/en not_active Expired
- 1986-05-23 ZA ZA863873A patent/ZA863873B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR861318B (en) | 1986-09-19 |
| BE904796A (en) | 1986-11-21 |
| LU86435A1 (en) | 1986-12-05 |
| JPS61271275A (en) | 1986-12-01 |
| DK240386A (en) | 1986-11-24 |
| FR2582309A1 (en) | 1986-11-28 |
| FI862124A7 (en) | 1986-11-24 |
| ES8802318A1 (en) | 1988-05-01 |
| NL8601188A (en) | 1986-12-16 |
| IT1203791B (en) | 1989-02-23 |
| SE8602308L (en) | 1986-11-24 |
| AU5763786A (en) | 1986-11-27 |
| FI862124L (en) | 1986-11-24 |
| HUT41737A (en) | 1987-05-28 |
| FI862124A0 (en) | 1986-05-21 |
| ZA863873B (en) | 1988-01-27 |
| IL78872A0 (en) | 1986-09-30 |
| IT8648050A0 (en) | 1986-05-23 |
| NZ216250A (en) | 1990-04-26 |
| FR2582309B1 (en) | 1989-08-18 |
| GB2175898B (en) | 1989-07-05 |
| ES555200A0 (en) | 1988-05-01 |
| SE8602308D0 (en) | 1986-05-21 |
| AU594954B2 (en) | 1990-03-22 |
| DK240386D0 (en) | 1986-05-22 |
| HU196376B (en) | 1988-11-28 |
| GB8612159D0 (en) | 1986-06-25 |
| GB2175898A (en) | 1986-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH23495A (en) | Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof | |
| PH23341A (en) | Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereof | |
| PT81007A (en) | Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same | |
| EP0214058A3 (en) | Pharmaceutical composition containing histamine derivatives | |
| PH24719A (en) | Cephem compound, pharmaceutical composition containing said compound and method of use thereof | |
| PH24749A (en) | Piperidine compounds, pharmaceutical composition and method of use thereof | |
| IL80160A0 (en) | Beta-lactam derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| PH22821A (en) | Phenyl butenamide, pharmaceutical composition containing said compound and method of use thereof | |
| PH24180A (en) | Macrolide compounds,pharmaceutical composition containing said compound and method of use thereof | |
| PT82984A (en) | Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same | |
| PH23447A (en) | B-actam compounds,pharmaceutical compositions containing the same and method of use thereof | |
| PH24093A (en) | Macrolide compounds,pharmaceutical composition containing same and method of use thereof | |
| PT83188A (en) | Process for the preparation of benzimidazole derivatives and of pharmaceutical compositions containing the same | |
| PT82395A (en) | Process for the preparation of synthetic derivatives of pseudopterosin and of pharmaceutical compositions containing the same | |
| PH23384A (en) | Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof | |
| ZA865328B (en) | Oxa-thia and d1-azabicycloalkane derivatives;process for their preparation and their use as pharmaceuticals | |
| PH21022A (en) | Phenylquinoline derivatives and pharmaceutical composition containing said compounds | |
| PT82772A (en) | Process for the preparation of novel glycerol derivatives and of pharmaceutical compositions containing the same | |
| PH24135A (en) | Quinoline derivatives and pharmaceutical composition containing said compounds | |
| PT82464A (en) | Process for the preparation of novel benzisoselenazolonyl derivatives and of pharmaceutical compositions containing the same | |
| PH21556A (en) | Phenyl nonatetraenoic acid derivatives, pharmaceutical compositions containing the same and method of use thereof | |
| AR242206A1 (en) | 3-dimethyl-mevalonic-acid derivatives, process for their preparation, pharmaceutical compositions based on these compounds, their use and intermediates | |
| EP0220653A3 (en) | 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, process for preparation and use thereof, and pharmaceutical composition containing the same | |
| PT82072B (en) | Process for the preparation of pyrazolopyridine derivatives and of pharmaceutical compositions containing the same | |
| EP0225866A3 (en) | Quinazoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use |